Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ari Melnick

Showing results (131-140 of 230) with videos related to

Pageof 23
Sort By:
Blood|August 2, 2018
Genetic and epigenetic evolution as a contributor to WT1-mutant leukemogenesisElodie Pronier, Robert L Bowman, Jihae Ahn, et al.
Cancer Research|July 1, 2010
DNMT3B7, a truncated DNMT3B isoform expressed in human tumors, disrupts embryonic development and accelerates lymphomagenesisMrinal Y Shah, Aparna Vasanthakumar, Natalie Y Barnes, et al.
The Journal of Experimental Medicine|October 7, 2015
Dose-dependent role of the cohesin complex in normal and malignant hematopoiesisAaron D Viny, Christopher J Ott, Barbara Spitzer, et al.
Cancer Research|October 11, 2017
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic LeukemiaNakhle S Saba, Deanna H Wong, Georges Tanios, et al.
The Journal of Clinical Investigation|July 20, 2018
Specific covalent inhibition of MALT1 paracaspase suppresses B cell lymphoma growthLorena Fontán, Qi Qiao, John M Hatcher, et al.
Blood|April 13, 2013
Downregulation of FOXP1 is required during germinal center B-cell functionAinara Sagardoy, Jose I Martinez-Ferrandis, Sergio Roa, et al.
Journal of the National Cancer Institute|December 18, 2016
General Biomarker Recommendations for LymphomaLisa Rimsza, Yuri Fedoriw, Louis M Staudt, et al.
Cancer Cell|December 15, 2012
MALT1 small molecule inhibitors specifically suppress ABC-DLBCL in vitro and in vivoLorena Fontan, Chenghua Yang, Venkataraman Kabaleeswaran, et al.
Cell Reports|May 6, 2014
CTCF haploinsufficiency destabilizes DNA methylation and predisposes to cancerChristopher J Kemp, James M Moore, Russell Moser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 26, 2014
Prolonged administration of azacitidine with or without entinostat for myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes: results of the US Leukemia Intergroup trial E1905Thomas Prebet, Zhuoxin Sun, Maria E Figueroa, et al.
Pageof 23

Showing results (131-140 of 230) with videos related to

Sort By:
Pageof 23
Blood|August 2, 2018
Genetic and epigenetic evolution as a contributor to WT1-mutant leukemogenesisElodie Pronier, Robert L Bowman, Jihae Ahn, et al.
Cancer Research|July 1, 2010
DNMT3B7, a truncated DNMT3B isoform expressed in human tumors, disrupts embryonic development and accelerates lymphomagenesisMrinal Y Shah, Aparna Vasanthakumar, Natalie Y Barnes, et al.
The Journal of Experimental Medicine|October 7, 2015
Dose-dependent role of the cohesin complex in normal and malignant hematopoiesisAaron D Viny, Christopher J Ott, Barbara Spitzer, et al.
Cancer Research|October 11, 2017
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic LeukemiaNakhle S Saba, Deanna H Wong, Georges Tanios, et al.
The Journal of Clinical Investigation|July 20, 2018
Specific covalent inhibition of MALT1 paracaspase suppresses B cell lymphoma growthLorena Fontán, Qi Qiao, John M Hatcher, et al.
Blood|April 13, 2013
Downregulation of FOXP1 is required during germinal center B-cell functionAinara Sagardoy, Jose I Martinez-Ferrandis, Sergio Roa, et al.
Journal of the National Cancer Institute|December 18, 2016
General Biomarker Recommendations for LymphomaLisa Rimsza, Yuri Fedoriw, Louis M Staudt, et al.
Cancer Cell|December 15, 2012
MALT1 small molecule inhibitors specifically suppress ABC-DLBCL in vitro and in vivoLorena Fontan, Chenghua Yang, Venkataraman Kabaleeswaran, et al.
Cell Reports|May 6, 2014
CTCF haploinsufficiency destabilizes DNA methylation and predisposes to cancerChristopher J Kemp, James M Moore, Russell Moser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 26, 2014
Prolonged administration of azacitidine with or without entinostat for myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes: results of the US Leukemia Intergroup trial E1905Thomas Prebet, Zhuoxin Sun, Maria E Figueroa, et al.
Pageof 23